EA201171211A1 - Производные оксадиазола - Google Patents

Производные оксадиазола

Info

Publication number
EA201171211A1
EA201171211A1 EA201171211A EA201171211A EA201171211A1 EA 201171211 A1 EA201171211 A1 EA 201171211A1 EA 201171211 A EA201171211 A EA 201171211A EA 201171211 A EA201171211 A EA 201171211A EA 201171211 A1 EA201171211 A1 EA 201171211A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxadiazol derivatives
oxadiazol
derivatives
compounds
useful
Prior art date
Application number
EA201171211A
Other languages
English (en)
Other versions
EA020691B1 (ru
Inventor
Анна Кваттропани
Сирил Монтань
Вольфганг Зауэр
Стефано Крозиньяни
Аньес Бомбрэн
Original Assignee
Мерк Сероно С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Сероно С.А. filed Critical Мерк Сероно С.А.
Publication of EA201171211A1 publication Critical patent/EA201171211A1/ru
Publication of EA020691B1 publication Critical patent/EA020691B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к соединениям формулы (I)где R, R, R, R, W, Q и S имеют значения, представленные в п.1 формулы изобретения. Соединения являются пригодными, например, в лечении аутоиммунных нарушений, таких как рассеянный склероз.
EA201171211A 2009-04-03 2010-03-29 Производные оксадиазола EA020691B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09157301A EP2241558A1 (en) 2009-04-03 2009-04-03 Oxadiazole derivatives
US16977309P 2009-04-16 2009-04-16
PCT/EP2010/054103 WO2010112461A1 (en) 2009-04-03 2010-03-29 Oxadiazole derivatives

Publications (2)

Publication Number Publication Date
EA201171211A1 true EA201171211A1 (ru) 2012-05-30
EA020691B1 EA020691B1 (ru) 2015-01-30

Family

ID=40792794

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201171211A EA020691B1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола
EA201171210A EA201171210A1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201171210A EA201171210A1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола

Country Status (16)

Country Link
US (2) US8802704B2 (ru)
EP (3) EP2241558A1 (ru)
JP (2) JP5833538B2 (ru)
KR (2) KR20120002606A (ru)
CN (2) CN102459206A (ru)
AR (2) AR076188A1 (ru)
AU (2) AU2010233932B2 (ru)
BR (2) BRPI1015048A2 (ru)
CA (2) CA2755918C (ru)
EA (2) EA020691B1 (ru)
ES (2) ES2639028T3 (ru)
IL (2) IL215498A (ru)
MX (2) MX2011010451A (ru)
SG (2) SG174449A1 (ru)
WO (2) WO2010115751A2 (ru)
ZA (2) ZA201106854B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives
TW201206429A (en) 2010-07-08 2012-02-16 Merck Serono Sa Substituted oxadiazole derivatives
KR101829086B1 (ko) 2010-10-14 2018-02-13 다이이찌 산쿄 가부시키가이샤 아실벤젠 유도체
WO2013108800A1 (ja) 2012-01-18 2013-07-25 第一三共株式会社 置換フェニルアゾール誘導体
WO2014008257A2 (en) 2012-07-02 2014-01-09 Monsanto Technology Llc Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles
PL2958913T3 (pl) 2013-02-20 2019-03-29 Lg Chem, Ltd. Agoniści receptora sfingozyno-1-fosforanowego, sposoby ich przygotowania i zawierające je jako środek aktywny farmaceutyczne kompozycje
CN103450171B (zh) * 2013-09-22 2015-07-08 苏州康乃德生物医药有限公司 一种免疫调节化合物、其用途和包含其的药物组合物
US9828351B2 (en) * 2014-06-26 2017-11-28 Monash University Enzyme interacting agents
MX2018005361A (es) * 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.
US11439623B2 (en) 2017-04-04 2022-09-13 Case Western Reserve University Method of modulating ribonucleotide reductase
US10676467B2 (en) 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof
CN107827837B (zh) * 2017-11-21 2021-09-24 苏州朗科生物技术股份有限公司 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用
CN109956912B (zh) * 2017-12-26 2021-10-22 中国医学科学院药物研究所 含二苯基噁二唑的羧酸类化合物、其制备方法及医药用途
CN109761827A (zh) * 2019-02-18 2019-05-17 湖南科瑞生物制药股份有限公司 一种n-苄基乙醇胺的制备方法
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用
CN116041277A (zh) * 2023-01-18 2023-05-02 中国药科大学 苯基和联苯基取代的五元杂环类化合物及其制备方法、药物组合物和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60330047D1 (en) * 2002-01-18 2009-12-24 Merck & Co Inc "n-(benzyl)aminoalkyl carboxylate, phosphinate, phosphonate und tetrazole als edg rezeptoragonisten"
EP1697333A4 (en) * 2003-12-17 2009-07-08 Merck & Co Inc 3,4-DISUSBSTITUTED PROPANOIC CARBOXYLATES AS S1P RECEPTOR AGONISTS (EDG)
BRPI0612028A2 (pt) 2005-06-08 2010-10-13 Novartis Ag oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p
GB0511684D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
WO2008037476A1 (en) * 2006-09-29 2008-04-03 Novartis Ag Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties
GB0625648D0 (en) * 2006-12-21 2007-01-31 Glaxo Group Ltd Compounds
JO2701B1 (en) * 2006-12-21 2013-03-03 جلاكسو جروب ليميتد Vehicles
SI2125797T1 (sl) * 2007-03-16 2014-03-31 Actelion Pharmaceuticals Ltd. Derivati amino-piridina kot agonisti receptorja s1p1/edg1
EP2014653A1 (en) * 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
KR20100075608A (ko) * 2007-10-04 2010-07-02 메르크 세로노 에스. 에이. 옥사다이졸 유도체
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives

Also Published As

Publication number Publication date
AU2010233932B2 (en) 2016-10-13
IL215497A0 (en) 2011-12-29
ES2639028T3 (es) 2017-10-25
WO2010112461A1 (en) 2010-10-07
AR076188A1 (es) 2011-05-26
CA2755918C (en) 2018-02-20
CN102459206A (zh) 2012-05-16
EA201171210A1 (ru) 2012-05-30
SG174448A1 (en) 2011-10-28
ZA201106854B (en) 2012-11-28
SG174449A1 (en) 2011-10-28
BRPI1013422A2 (pt) 2016-04-05
US8815919B2 (en) 2014-08-26
AU2010230314B2 (en) 2016-07-21
AR076187A1 (es) 2011-05-26
BRPI1015048A2 (pt) 2019-09-24
IL215497B (en) 2018-12-31
US8802704B2 (en) 2014-08-12
ZA201106855B (en) 2012-11-28
ES2652183T3 (es) 2018-01-31
IL215498A0 (en) 2011-12-29
EP2241558A1 (en) 2010-10-20
AU2010233932A1 (en) 2011-10-13
CA2755918A1 (en) 2010-10-14
KR20110135987A (ko) 2011-12-20
KR20120002606A (ko) 2012-01-06
EP2414341A2 (en) 2012-02-08
EA020691B1 (ru) 2015-01-30
WO2010115751A2 (en) 2010-10-14
MX2011010451A (es) 2011-11-18
IL215498A (en) 2017-11-30
US20120022109A1 (en) 2012-01-26
CN102803238A (zh) 2012-11-28
JP2012522744A (ja) 2012-09-27
EP2414342B1 (en) 2017-05-31
JP2012522745A (ja) 2012-09-27
EP2414342A1 (en) 2012-02-08
AU2010230314A1 (en) 2011-10-13
CN102803238B (zh) 2015-09-30
MX2011010449A (es) 2011-11-18
CA2755928C (en) 2017-06-20
WO2010115751A3 (en) 2010-12-16
CA2755928A1 (en) 2010-10-07
EP2414341B1 (en) 2017-09-13
US20120035226A1 (en) 2012-02-09
JP5833537B2 (ja) 2015-12-16
JP5833538B2 (ja) 2015-12-16

Similar Documents

Publication Publication Date Title
EA201171211A1 (ru) Производные оксадиазола
EA201070422A1 (ru) Производные оксадиазола
EA201070423A1 (ru) Диарильные соединения оксадиазолов
EA201070238A1 (ru) Соединения пиримидина
EA201070779A1 (ru) Триазолсодержащие производные оксадиазола
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
MX2012008049A (es) Compuestos heterociclicos triciclicos, composiciones y metodos de uso de los mismos,.
EA201490357A1 (ru) Индазолы
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201200119A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA201300282A1 (ru) Производные триазолопиразина
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
EA201291236A1 (ru) Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10
MA32811B1 (fr) Nouveaux composés
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA200901124A1 (ru) Соединения формулы (i) в качестве ингибиторов серинпротеазы
EA201100299A1 (ru) Органические соединения
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
EA201100503A1 (ru) Глюкозидные производные и их применения
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
MA32505B1 (fr) 5-alcynyl-pyrimidines
EA201000550A1 (ru) Производные тиазола

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU